Transforming viral vector manufacturing with next-generation CGMP plasmids platform

John Bowen, Brian Tomkowicz

02 April 2025

Register

Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings

Kasey Kime, Xiao Peng

20 March 2025

Innovator Insight

Streamlining the supply chain: insights on raw material sourcing and quality by design

Lara Silverman

19 March 2025

Interview

GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing

Lili Belcastro, Basak Clements, Claire Wartel

18 March 2025

Watch

Choosing the best path to patients: how to decide between in-house and outsourced iPSC therapy development and manufacturing

Laura Koivusalo, Anni Mörö, Ross Macdonald

11 March 2025

Commentary

Enabling allogeneic cell therapy development: scaling up generation of PSC-derived NK cells

Mark Kennedy, Marcus Bunn

10 March 2025

Innovator Insight

Raw and starting materials for cellular and gene therapy products

Gary du Moulin

04 March 2025

Review

Worth the switch? Enhancing process performance for cell therapy manufacturing with an animal component-free raw material strategy

Phil Morton, Shanya Jiang

03 March 2025

Innovator Insight

Maximizing CAR-T cell yields: scalable solutions with perfusion and stirred-tank bioreactors

J Hengst, Q Rafiq, R Ladi et al

27 February 2025

Innovator Insight

Investing in early-stage stem cell therapy developers

Stijn Heessen, Kristian Tryggvason

21 February 2025

Viewpoint

Advancing AAV manufacturing: strategic insights and cost-effective solutions for the future of gene therapies

Michael DiBiasio-White, Ying Cai, Roland Pach

06 February 2025

Watch

Driving innovation in cell and gene therapy: the role of AI and robotics

Kenneth Harris, Mitchel Sivilotti, Anthony Rotunno

27 January 2025

Interview

What removing the DNA synthesis bottleneck means for the future of drug discovery and development

Elizabeth Wood

14 January 2025

Interview

Connecting innovations to great gains for the ultimate stakeholder: the patient

Michelle Berg

13 January 2025

Foreword

Personalization in advanced cellular ImmunoTherapeutics: activities in Ireland

Athanasios Mantalaris, Nicki Panoskaltsis, Fiona Killard

13 January 2025

Commentary

Preserving the future of medicine: standardizing leukapheresis materials with cryopreservation for scalable cell therapies

R Luke, M Giedlin, D Clarke et al

12 December 2024

Watch

Next-generation risk mitigation in the temperature-controlled supply chain for advanced therapies with ISO 21973 compliance

Edward Grimley, Leanne Kodsmann

04 December 2024

Innovator Insight

Operations strategy for a scalable CGT supply chain: key CXO insights

Shesh Sharma, Tim Sirichoke, Edward Ballesteros

02 December 2024

Expert Insight

When does outsourcing autologous collection center qualification and the cell therapy supply chain make sense?

Amy Hines, Jeni Newman, Marcel van Houten

14 November 2024

Watch

Supply chain sourcing and sustainability strategies for cell therapy and advanced biomaterial products

Raj Joshi

04 November 2024

Interview

Trends in innovation for enhanced gene therapy downstream process intensification and product yield

Rachel Legmann

28 October 2024

Poster